Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a multicentre prospective, randomized, double-blind and imitation, positive-drug parallel controlled clinical trail. The objective of this study is to evaluate the efficacy and safety of Huaiqihuang Granule in patients with CKD stage 3 primary glomerulonephritis.
Epistemonikos ID: d477d5ac020f06f15ee0ac8474ef0203fdab775c
First added on: May 07, 2024